Related Experiment Video
Updated: Jun 5, 2026
08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Thrombocytopenia in chronic hepatitis C.
Mihai Olariu1, Cristina Olariu, Dan Olteanu
1National Institute of Infectious Diseases "Prof.Dr.Matei Balş" Bucharest, Romania. ol_mihai@yahoo.com
Journal of Gastrointestinal and Liver Diseases : JGLD
|December 29, 2010
Summary
Chronic hepatitis C often causes thrombocytopenia through bone marrow inhibition and autoimmune destruction. Advanced liver fibrosis significantly impacts platelet count, with both mechanisms frequently involved in severe cases.
Area of Science:
- Hepatology
- Immunology
- Hematology
Background:
- Chronic hepatitis C can lead to thrombocytopenia due to bone marrow suppression, reduced thrombopoietin, or autoimmune processes.
- Factors like age, gender, liver disease severity, and viral load may influence platelet reduction.
- Understanding the mechanisms and predictors of thrombocytopenia in hepatitis C is crucial for patient management.
Purpose of the Study:
- To identify the primary mechanisms causing thrombocytopenia in chronic hepatitis C patients.
- To determine clinical predictors associated with the severity of thrombocytopenia.
Main Methods:
- Bone marrow biopsy assessed central (viral inhibition) mechanisms.
- ELISA detected antiplatelet antibodies for peripheral (autoimmune) mechanisms.
- Clinical data included age, gender, ALT, fibrosis stage, and HCV RNA.
Main Results:
- Combined central and peripheral mechanisms were prevalent in severe (93.3%) and moderate (61.53%) thrombocytopenia.
- Autoimmune destruction was the sole mechanism in 85% of mild thrombocytopenia cases.
- Thrombocytopenia correlated significantly with ALT levels, viral load, and liver fibrosis stage.
Conclusions:
- Chronic hepatitis C is linked to variable thrombocytopenia, often involving both central and peripheral mechanisms.
- Platelet count generally decreases as liver disease advances.
- Liver fibrosis stage is a key determinant of thrombocytopenia severity in chronic hepatitis C.
More Related Videos
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...